Entrada Therapeutics Statistics
Total Valuation
TRDA has a market cap or net worth of $316.00 million. The enterprise value is -$44.79 million.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TRDA has 35.63 million shares outstanding. The number of shares has increased by 18.01% in one year.
| Current Share Class | 35.63M |
| Shares Outstanding | 35.63M |
| Shares Change (YoY) | +18.01% |
| Shares Change (QoQ) | +5.96% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 52.86% |
| Float | 19.02M |
Valuation Ratios
The trailing PE ratio is 5.28.
| PE Ratio | 5.28 |
| Forward PE | n/a |
| PS Ratio | 1.57 |
| Forward PS | 7.55 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.15, with a Debt / Equity ratio of 0.14.
| Current Ratio | 11.15 |
| Quick Ratio | 10.78 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.92 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 19.56% and return on invested capital (ROIC) is 7.36%.
| Return on Equity (ROE) | 19.56% |
| Return on Assets (ROA) | 5.90% |
| Return on Invested Capital (ROIC) | 7.36% |
| Return on Capital Employed (ROCE) | 9.66% |
| Revenue Per Employee | $1.15M |
| Profits Per Employee | $358,612 |
| Employee Count | 183 |
| Asset Turnover | 0.42 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TRDA has paid $859,000 in taxes.
| Income Tax | 859,000 |
| Effective Tax Rate | 1.29% |
Stock Price Statistics
The stock price has decreased by -28.27% in the last 52 weeks. The beta is 0.03, so TRDA's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | -28.27% |
| 50-Day Moving Average | 10.08 |
| 200-Day Moving Average | 14.85 |
| Relative Strength Index (RSI) | 48.32 |
| Average Volume (20 Days) | 182,993 |
Short Selling Information
The latest short interest is 1.10 million, so 3.08% of the outstanding shares have been sold short.
| Short Interest | 1.10M |
| Short Previous Month | 1.17M |
| Short % of Shares Out | 3.08% |
| Short % of Float | 5.77% |
| Short Ratio (days to cover) | 7.16 |
Income Statement
In the last 12 months, TRDA had revenue of $210.78 million and earned $65.63 million in profits. Earnings per share was $1.68.
| Revenue | 210.78M |
| Gross Profit | 85.48M |
| Operating Income | 47.01M |
| Pretax Income | 40.51M |
| Net Income | 65.63M |
| EBITDA | 50.78M |
| EBIT | 47.01M |
| Earnings Per Share (EPS) | $1.68 |
Full Income StatementBalance Sheet
The company has $420.00 million in cash and $59.21 million in debt, giving a net cash position of $360.79 million or $10.13 per share.
| Cash & Cash Equivalents | 420.00M |
| Total Debt | 59.21M |
| Net Cash | 360.79M |
| Net Cash Per Share | $10.13 |
| Equity (Book Value) | 428.68M |
| Book Value Per Share | 12.04 |
| Working Capital | 400.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$41.56 million and capital expenditures -$3.16 million, giving a free cash flow of -$44.72 million.
| Operating Cash Flow | -41.56M |
| Capital Expenditures | -3.16M |
| Free Cash Flow | -44.72M |
| FCF Per Share | -$1.26 |
Full Cash Flow StatementMargins
Gross margin is 40.55%, with operating and profit margins of 22.30% and 31.13%.
| Gross Margin | 40.55% |
| Operating Margin | 22.30% |
| Pretax Margin | 31.54% |
| Profit Margin | 31.13% |
| EBITDA Margin | 24.09% |
| EBIT Margin | 22.30% |
| FCF Margin | n/a |
Dividends & Yields
TRDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.01% |
| Shareholder Yield | -18.01% |
| Earnings Yield | 20.77% |
| FCF Yield | -14.15% |
Analyst Forecast
The average price target for TRDA is $25.67, which is 187.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.67 |
| Price Target Difference | 187.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | -34.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TRDA has an Altman Z-Score of 4.53 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.53 |
| Piotroski F-Score | 5 |